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Nasal  saline  irrigation:  therapeutic  or homeopathicrap
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dIrrigac¸ão nasal  com  soluc¸ão  salina:  te
In  chronic  rhinosinusitis  (CRS),  and  many  chronic  airway  con-
ditions,  the  underlying  goal  is  to  restore  mucosal  function
with  treatments  focused  on  reducing  inﬂammation,  remov-
ing  bacterial  infection  (or  bioﬁlm)  and,  critically,  replacing
lost  mucociliary  function.1 Nasal  irrigations  have  come  to
play  a  large  role  in  the  management  of  chronic  rhinosinusitis
and  to  a  lesser  degree  in  allergic  rhinitis  (AR).  While  saline
nasal  treatments  are  offered  in  different  forms,  such  as
sprays  and  nebulizers,  it  is  high-volume  nasal  irrigation  that
has  found  an  integral  part  in  current  treatment  guidelines
for  CRS.
Nasal  irrigations  may  appear  novel,  but  this  practice  of
sinus  care  has  its  origins  within  the  Hatha  Yoga  Pradipika
from  the  15th  century.  Jala  neti  is  the  practice  of  water
(Jala)  irrigation  and  thus  the  origins  of  the  neti  pot.  There
are  several  Shuddikriyas, or  body  cleansing  practices,  within
yogic  traditions  and  neti  refers  to  nasal  cleansing.  Other
cleansing  techniques  include  the  use  of  string  (Sutra), ghee
(Ghrita),  and  even  one’s  own  urine  (Swamootra). However
it  is  Jala  neti, or  saline  irrigation,  that  has  demonstrated
effectiveness  (thankfully).
Western  medicine  has  not  been  ignorant  of  its  bene-
ﬁts;  the  ﬁrst  description  of  nasal  irrigation  appeared  in
the  British  Medical  Journal  in  1895.  In  2007,  a  Cochrane
review  on  nasal  saline  therapy  demonstrated  a  large  shift
in  symptom  improvement  on  meta-analysis  of  randomized
controlled  trials,  with  a  1.41  standardized  mean  differ-
ence  (SMD)  in  favor  of  saline  therapy.2 This  represents
an  improvement  of  1.41  standard  deviations  on  the  symp-
tom  scale  compared  to  placebo  and  compares  favorably
to  the  treatment  effect  observed  in  other  sinonasal  inter-
ventions  with  intranasal  corticosteroids  for  CRS  (SMD  0.49)
and  immunotherapy  for  AR  (SMD  0.71).  This  large  symp-
tom  effect  underscores  its  growing  popularity.  While  many
alternative  therapies  lie  on  a  spectrum  from  plausible  to
preposterous,  nasal  irrigation  rests  on  the  former  end  of  the Please cite this article as: Barham HP, Harvey RJ. Nasal saline
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pectrum,  not  only  for  its  effectiveness,  but  also  for  the
ubstantive  research  underlying  its  effect.
Nasal  irrigation  is  primarily  a  mechanical  intervention.  It
oes  not  directly  enhance  mucosal  immunity  (and  may  tem-
orarily  remove  innate  factors),  nor  is  it  a  decongestive.
ery  hypertonic  saline  only  acts  as  a  provocation  to  the  air-
ay  and  is  used  by  respiratory  physicians  for  that  purpose.
dditionally,  it  does  not  directly  enhance  ciliary  function.
or  many  hypersecretory  conditions,  such  as  CRS,  it  may
elp  to  temporarily  improve  mucus  rheology  but  it  is  the
echanical  removal  of  inﬂammatory  mucin  that  improves
ucociliary  function.
In  CRS,  mucostasis  is  a  major  component  of  the  patho-
hysiology.  Although  mucociliary  dysfunction  may  be  a
rimary  factor  in  conditions  such  as  cystic  ﬁbrosis,  it  is  usu-
lly  a  secondary  event  caused  by  inﬂammation,  appearing
n  chronic  airway  conditions  such  as  eosinophilic  CRS  or
ronchiectasis.  Loss  of  ciliated  mucosa  and  squamous  meta-
lasia  are  part  of  the  chronic  remodeling  changes  seen  in
RS.3 As  in  the  lower  airway,  some  of  these  changes  may
ot  be  immediately  reversible,  and  the  role  of  nasal  saline
rrigation  is  to  overcome  the  acquired  mucostasis.  The  abil-
ty  to  temporarily  (or  permanently)  substitute  for  impaired
ucociliary  clearance  is  essential  to  successful  sinus  man-
gement.
The  role  of  the  surgeon  is  critical  for  effective  nasal
aline  irrigation  therapy.  Endoscopic  sinus  surgery  (ESS)
mproves  the  access  of  topical  therapies  for  both  the
echanical  lavage  of  mucinous  products  and  drug  delivery.4
elivery  of  nasal  saline  and  additional  topical  therapies
s  best  achieved  with  large  volume  devices.5 Low-volume
evices  do  not  reliably  penetrate  the  sinuses,  and  although
asal  cavity  delivery  occurs,  this  is  not  true  sinus  therapy.
igh-volume  devices  (>60  mL,  but  generally  >100  mL)  have
een  found  to  improve  delivery  into  the  sinuses.5,6 The  def-
nition  of  ‘‘high-volume’’  is  arbitrary,  but  clinical  evidence
uggests  it  is  important  for  mechanical  lavage  and  drug
elivery.7 Unfortunately,  high-volume  devices  can  produce
ustachian  tube  symptoms  and  local  irritation  in  10--20%
f  users.  However,  these  are  often  mild  and  compliance  is
igh.2
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Low-volume  devices  such  as  drops,  sprays,  and  nebulizers
re  nasal  cavity  therapies,  and  are  used  in  the  manage-
ent  of  AR,  but  have  a  limited  a  role  in  managing  CRS,  as
hey  have  limited  reach  within  the  sinuses  and  provide  no
echanism  for  correcting  mucostasis  via  lavage.
onclusion
asal  saline  solutions  are  helpful  in  reducing  mucosal
nﬂammation,  removing  bacterial  products,  and  improving
inonasal  function  in  CRS.  Nasal  irrigation  enables  effec-
ive  local  pharmacologic  management  when  true  sinus
istribution  of  topical  therapies  is  required,  primarily  cor-
icosteroids,  antibiotics,  and  mucolytics.  The  mechanical
hear  force  that  is  provided  by  high  volume  irrigations  in
he  post-operative  state  is  likely  a  major  factor  to  manage
ucostasis.  Current  evidence  suggests  that  optimal  topi-
al  sinus  delivery  occurs  after  surgery  and  with  high-volume
rrigation  devices.  Most  importantly,  they  are  a  low-cost  and
ell  tolerated  therapy  for  patients  with  CRS.
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